The present study was designed to determine the effect of recombinant endothelial nitric oxide synthase (eNOS) gene expression on reactivity of canine basilar arteries to en dothelin-\ (ET-I). Experiments were performed ex vivo. The arteries were exposed (30 minutes at 37°C) to adenoviral vec tors encoding eNOS gene (AdCMVeNOS) or f3-galactosidase reporter gene (AdCMVf3-Gal). Twenty-four hours after trans duction, transgene expression was evident mainly in the vas cular adventitia. Rings of control (nontransduced), AdCMVf3-Gal-and AdCMVeNOS-transduced arteries with and without endothelium were suspended for isometric tension recording. Levels of guanosine 3',5' -cyclic monophosphate (cGMP) were measured by radioimmunoassay. During contractions to uri dine 5'-triphosphate, ET-\ (10-1 0 to 3xlO-9 mollL) caused further increase in tension in control and AdCMVf3-Gal-transduced arteries. In contrast, ET -\ caused concentration-dependent re laxations of AdCMVeNOS-transduced arteries. The relaxations to ET -I in AdCMVeNOS-transduced arteries were endothe lium-independent They were abolished by NG-nitro-L-arginine Endothelin (ET)-1 is a potent vasoconstrictor peptide (Yanagisawa et aI., 1988), and it is generally accepted that ET -1 may be an important substance involved in the pathogenesis of a number of cardiovascular disorders including systemic hypertension, pulmonary hyperten sion, coronary arterial spasm, and atherosclerosis (Ivy et Abbreviations used: eNOS, endothelial nitric oxide synthase; ET, endothelin; L-NAME, N G -nitro-L-arginine methyl ester; NO, nitric ox ide; PBS, phosphate-buffered saline; UTP, uridine 5 'triphosphate.
methyl ester or by chemical treatment of adventitia with para formaldehyde before gene transfer. ET-l (10-9 mollL) signifi cantly increased intracellular cGMP levels in AdCMVeNOS transduced arteries without endothelium. In arteries transduced with AdCMVeNOS, higher concentrations (10-9 to 3xlO-8 moUL) of ET-2 also caused relaxations, whereas ET-3 and sarafotoxin, a selective ET I3 receptor agonist, did not produce any relaxations. The relaxations to ET-l in AdCMVeNOS transduced arteries were strongly reduced by , an ETA receptor antagonist, but were not affected by , aI., 1997; Lerman et aI., 1991; Nayler, 1990; Steward et aI., 1991) , In the cerebral circulation, ET-l is regarded as a putative mediator of cerebral vasospasm, which is a major cause of morbidity and mortality in patients with subarachnoid hemorrhage (Asano et aI., 1989; Cosentino and Katusic, 1994; Suzuki et aI., 1992; Willett et aI., 1994; Zuccarello et aI., 1996) , Nitric oxide (NO), produced by endothelial nitric ox ide synthase (eNOS), is a potent vasodilator and plays an essential role in the regulation of vascular tone (Bredt and Snyder, 1994; Moncada, Palmer and Higgs, 1991) , A recent advance in recombinant DNA technology has made it possible to increase local NO production in the vascular wall by increasing expression of eNOS (Jans sens et aI., 1996; von der Leyen et aI., 1995) . Our pre vious in vitro and in vivo studies have confirmed that recombinant eNOS gene can be transferred using adeno viral vectors into adventitial layer overlying canine ce rebral arteries, and that expression of eNOS gene in the adventitia can augment vasodilator effect of bradykinin and calcium ionophore A23187 (Chen et aI., 1997a,b; Tsutsui et aI., 1998) . During preliminary studies, we no ticed that expression of recombinant eNOS gene in ca nine basilar arteries could convert the contractile re sponses to ET -1 into relaxations. This observation sug gested that successful transfer and expression of recombinant eNOS gene may lead to a qualitative change in responsiveness of cerebral arteries to vasoconstrictor substances. Therefore, the present study was designed to characterize the mechanism of ET -I-induced relaxations of isolated canine basilar arteries expressing recombinant eNOS gene.
MATERIALS AND METHODS

Construction, propagation, and purification of adenoviral vectors
The adenoviral vector encoding eNOS gene (AdCMVeNOS), driven by the cytomegalovirus immediate early promoter, was generated through homologous recombination (Spector and Sa maniego, 1995) . These vectors, based on serotype 5 wild ad enovirus, have been made replication-deficient by a deletion of the early region I (E l), followed by an insertion of the cDNA sequence for bovine aortic endothelial cell eNOS (kindly pro vided by Dr. David G. Harrison, Emory University, Atlanta, GA). The gen�ration, propagation, purification, and evaluation of the adenoviral vector containing eNOS gene were described in detail previously (Chen et aI., 1997b 
Gene transfer
All procedures were in accordance with the institutional guidelines of the Mayo Clinic. Experiments were performed ex vivo on rings (3-mm long) of basilar arteries taken from mon grel dogs (15 to 20 kg), anesthetized with 30 mg/kg (intrave nous) sodium pentobarbital. To remove intraluminal blood, ar terial rings were gently rinsed with cold modified Krebs-Ringer bicarbonate solution (control solution) consisting of NaCI J 18.3, KCI 4.7, CaCl 2 2.5, MgS04 1.2, KH2P04 1.2, NaHC0 3 25.0, calcium-ethylenediamine-tetraacetic acid (EDTA) 0.026 and glucose 11.1 (mmollL). In certain rings, the endothelium was removed mechanically. Endothelial removal was accom plished by gently sliding an arterial ring over a steel needle (19 to 22 gauge) abraded by sandpaper, using two pairs of fine forceps under a microscope. The rings were assigned randomly for gene transfer. Cerebral arteries do not have external elastic lamina (Lee, 1995; Rosenblum, 1994) , and it is impossible to mechanically remove the adventitia. Therefore, to disrupt func tion of the adventitial layer it was chemically treated with para formaldehyde (the artery placed on a steel needle was soaked into phosphate-buffered saline [PBS] solution containing 4% paraformaldehyde for 15 seconds). Arterial rings were then incubated with adenoviral vectors (10 1 0 pfu/mL) in minimum essential medium (MEM; containing 0.1 % bovine serum albu min, 100 U/mL penicillin and 100 fLg/mL streptomycin) for 30 minutes at 37°C. This was followed by incubation in fresh MEM for 24 hours at 37°C in a CO2 incubator (5% COi95% air; Forma Scientific, Inc.).
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Analyses of vascular reactivity
Twenty-four hours after gene transfer, each ring was con nected to an isometric force transducer (Grass FT03; Grass Instrument Co.) and suspended in an organ chamber filled with 25 mL modified Krebs-Ringer bicarbonate solution (control solution; pH 7.4, 37°C) aerated with 94% O2-6% CO2, Iso metric tension was recorded continuously. The rings were al lowed to stabilize at a resting tension of 0. 2 to 0.4 g for 1 hour.
Each ring was then gradually stretched to the optimal point of its length-tension curve (approximately 3.0 g) as determined by the contraction to 10-5 mollL uridine 5' -triphosphate (UTP) (Katusic et aI., 1987) . All experiments were performed in the presence of 10-5 mollL indomethacin to exclude the possible influence of endogenous cyclo-oxygenase. To evaluate relax ation responses, the rings were contracted with UTP (3xlO-6 to 10-5 mollL) before the addition of agonists. Concentration response curves were obtained in a cumulative fashion. Several rings prepared from the same artery were studied in parallel.
The relaxations were expressed as a percentage of maximal relaxations induced by 3x 10-4 mollL papaverine added at the end of each experiment. In experiments with diethylamine NONOate (DEA-NONOate), the median effective concentra tion (EC 5 0 ) was calculated for each ring by linear interpolation between the two concentrations evoking responses just above and below 50% of the maximum.
Measurement of cGMP
A radioimmunoassay technique was used to determine the tissue content of guanosine 3' ,5' -cyclic monophosphate (cGMP). Twenty-four hours after gene transfer, 10-5 mollL indomethacin and 10-3 mollL 3-isobutyl-I -methylxanthine were added to the incubation medium containing arterial rings without endothelium, to eliminate the influence of cyclo oxygenase and to inhibit the degradation of cGMP by phos phodiesterases, respectively. After the incubation for 30 min utes, certain rings were stimulated with 10-9 mollL ET-I for 2 minutes. Then the rings were removed from the medium and immediately frozen in liquid nitrogen. Samples were homog enated in a cooled solution of 100% ethanol and I N HCl.
Samples were then centrifuged (4000 rpm, at 4°C for 10 min utes) and supernatant poured into a clean tube and placed in a 5SOC water bath under nitrogen to dry off the ethanol. After the tube was dry the sample was reconstituted with a Tris buffer.
The assay was run using a kit from Amersham. Protein assay was conducted by a DC Protein Assay Kit (Bio-Rad). This assay is similar to the procedure described by Lowry.
Drugs
The following pharmacological agents were used: ET-I, ET- 
Statistical analysis
The results are expressed as means± SD; n refers to the number of animals studied. Each set of concentration-response relationship was statistically analyzed by repeated measures analysis of variance (RM-ANOVA). Levels of f)-galactosidase and cGMP, and EC 5 0 values in response to DEA-NONOate in 
RESULTS
Relaxations to ET-l
During contractions induced by UTP (10-5 M), ET-1 (10-10 to 3xlO-9 mollL) caused concentration-dependent relaxations of AdCMVeNOS-transduced basilar arteries ( Fig. 1 A) . In contrast, ET -1 caused only additional con tractions in control (nontransduced) and AdCMV[3-Gal transduced arteries The relaxations to ET -1 were not af fected by the removal of endothelial cells (Fig. lB) . The typical responses to ET -1 in AdCMV[3-Gal-and AdCMVeNOS-transduced arteries without endothelium are presented in Fig. 2 . The relaxations to ET -1 in en dothelium-denuded arteries after eNOS gene transfer were abolished in the presence of L-NAME (3xlO-4 moll L), an inhibitor of nitric oxide synthase (NOS) (Fig. 3) .
Effect of chemical treatment of adventitia on gene transfer and vascular reactivity
Twenty-four hours after exposure to AdCMV[3-Gal and AdCMVeNOS, expression of recombinant proteins was evident mainly in the adventitia (Fig. 4) . Chemical treatment of arterial adventitia with paraformaldehyde before gene transfer, abolished expression of recombi nant proteins detected by histochemical or immunohis tochemical staining. Abolition of [3-galactosidase protein expression in those chemically treated arteries was veri fied also by ELISA (Table 1) . The same treatment abol- triphosphate. Data are shown as means ± SO and are expressed as percent of maximal relaxations induced by papaverine (3x10-4 mol/L); 100% = 3.1 ± 0.6 g (n = 9), 2.7 ± 0.8 g (n = 9) and 2. 7 ± 0.9 g (n = 9; A), and 3.1 ± 0.5 g (n = 9), 2. 7 ± 0.8 g (n = 9) and 3.3 ± 0.9 g (n = 9; B), for Control, j3-Gal gene-transduced, and eNOS gene-transduced arteries, respectively. Effect of endothelin-1 in eNOS arteries was significantly different from corresponding control and j3-Gal arteries; P < .05 by repeated measure analysis of variance. I I ished the relaxations to ET-I in AdCMVeNOS-trans duced arteries (Fig. 3) . In contrast, paraformaldehyde did not reduce relaxations to DEA-NONOate, a donor of nitric oxide (Table 2) .
Relaxations to ET-l, ET-2, ET-3, and sarafotoxin
Relaxations to ET-I, ET-2, ET-3, and sarafotoxin, a selective ET B receptor agonist, were compared in AdCMVeNOS-transduced basilar arteries without endo thelium (Fig. SA) . ET-2 caused relaxations in AdCMVeNOS-transduced arteries, however, the concen trations reqrfired to induce detectable and maximal re laxations were higher than those of ET -I. In arteries contracted with UTP, ET-3, and sarafotoxin caused only further increase in vascular tone.
Effect of BQ-123 and BQ-788 on relaxations
to ET-l Relaxations to ET-I in AdCMVeNOS-transduced bas ilar arteries without endothelium, were studied in the presence of BQ-123, a selective ETA receptor antagonist, or BQ-788, a selective ET B receptor antagonist (Fig. SB) . BQ-123 (10-7 mol/L) abolished the relaxations to ET-l. In contrast, BQ-788 in the same concentration (10-7 mol! L; data not shown) and even in a higher concentration (3xlO-7 mollL) did not affect the relaxations to ET-I ( Fig. SB) .
Contractions to ET-l
ET -J (10-10 to 10-8 mol/L) caused concentration dependent increase in base line tension in basilar arteries that were not contracted by UTP. These contractions were significantly smaller in AdCMVeNOS-transduced arteries compared to those in AdCMVj3-Gal-transduced arteries (Fig. 6) . In contrast, contractile responses to UTP were not different between AdCMVj3-Gal-transduced and AdCMVeNOS-transduced arteries (Fig. 7) .
Measurement of intracellular cGMP
No significant difference was detected in basal cGMP levels among control, AdCMVj3-Gal-transduced and AdCMVeNOS-transduced basilar arteries without endo-J Cereb Blood Flow Metab, Vol. 19, No.9, 1999
FIG. 2. Typical recordings of responses
to endothelin-1 in AdCMVj3-Gal-trans duced and AdCMVeNOS-transduced basilar arteries without endothelium. Re sponses were obtained during contrac tions induced by uridine 5' -triphosphate (UTP; 10-5 moIlL). thelium (Fig. 8 ). ET-I (l0-9 mollL) significantly in creased cGMP level only in AdCMVeNOS-transduced arteries (Fig. 8) .
DISCUSSION
This is the first study to examine the vascular reactiv ity to endothelins in cerebral arteries expressing recom binant eNOS gene. The major new findings are that (1) expression of recombinant eNOS gene causes reversal of vasoconstrictor effects of ET -I into vasodilatation, and 10-4 mol/L) and chemical treatment of adventitia with paraform aldehyde (PFA) on relaxations to endothelin-1 in AdCMVeNOS transduced (eNOS) basilar arteries without endothelium. Re sponses were evaluated during contractions induced by uridine 5'-triphosphate. Data are shown as mean ± SD and are ex pressed as percent of maximal relaxations induced by papaver ine (3 x 10-4 moIlL); 100% = 4.0 ± 1. 4 g (n = 5), 4. 5 ± 0.9 g (n = 5), and 3. 5 ± 0.7 g (n = 5) for untreated arteries and arteries treated with L-NAME and PFA, respectively. Effects of endothe lin-1 in L-NAME and PFA treated arteries were significantly dif ferent from control; P < .05 by repeated measure analysis of variance. that (2) this reversal is mediated by activation of adven titial ETA receptors and subsequent increased formation of NO. Successful gene transfer and expression of recombi nant proteins was confirmed by (3-galactosidase histo chemistry and eNOS immunohistochemistry. Positive staining of these recombinant proteins was detected pre dominantly in the vascular adventitia, being consistent with results of our previous ex vivo and in vivo gene transfer studies (Chen et aI., 1997a,b; Tsutsui et aI., 1998) . In canine basilar arteries transduced with AdCMVeNOS, ET -1 produced concentration-dependent relaxations during contractions to UTP, however, it caused only additional contractions in nontransduced control arteries and AdCMV(3-Gal-transduced arteries. In certain vascular beds, ET -1 reportedly can induce re laxations by a release of vasodilator substances including NO and prostacyclin from the endothelium (Ohlstein et aI., 1990; Pinheiro and Malik, 1993) , or by a direct ac- tivation of potassium channels on smooth muscle cells (Hasunuma et aI., 1990) . In contrast, in canine cerebral arteries ET -1 causes only contractions (present study; Asano et aI., 1989; Saito et aI., 1991) . Thus, ET-l induced relaxations observed in the present study repre sent a phenomenon specific for genetically engineered arteries. The relaxations to ET -1 of AdCMVeNOS transduced arteries were mediated by production of NO, since L-NAME, an inhibitor of NOS, abolished the re laxations, and ET -I significantly increased cGMP levels in the vascular wall. The increased cGMP levels in re sponse to ET -I were not detected either in non transduced control vessels or AdCMV(3-Gal-transduced arteries, showing the selective effect of eNOS gene transfer on cGMP formation in response to ET-l.
RECOMBINANT ENDOTHELIAL NOS GENE !O33
Our results show that the treatment of adventitia with paraformaldehyde before gene transfer abolished trans gene expression of recombinant proteins. We used this expressed as percent of maximal relaxations induced by papaverine (3 x 10-4 mol/l); 100% = 3. 7 ± 0.5 9 (n = 7), 4.5 ± 1. 1 9 (n = 7),3.7 ± 0.6 9 (n = 7), and 4.4 ± 0.8 9 (n =7 ) for ET-1, ET-2, ET-3 and sarafotoxin (A), and 3.8 ± 0.5 9 (n = 5), 3.5 ± 0. 6 9 (n = 5) and 3. 6 ± 0.9 9 (n = 5) for untreated arteries and arteries treated with 80-123 and 80-788 (8), respectively.
technique to confirm that the effect of eNOS gene trans fer on vasoreactivity to ET -1 was mediated by adventitial expression bf recombinant eNOS. It is not feasible to mechanically remove the adventitial layer of cerebral arteries because cerebral arteries do not have external elastic lamina (Rosenblum, 1994) . The chemical treat ment of adventitia can be used to selectively disrupt the adventitial function because this treatment did not affect the smooth muscle functions. Contractile responses to UTP and ET -1 ( Fig. 3) and relaxations to DEA- § c:
Endothelin-1 (-log M)
NONOate (Table 2) , a donor of NO, were maintained in paraformaldehyde-treated arteries. The chemical treat ment of adventitia abolished the relaxations to ET -1 in AdCMVeNOS-transduced arteries, indicating that the re laxant effect of ET -1 was dependent on the presence of intact adventitia. Thus, these findings reinforce the idea that ET-l stimulates NO production in the vascular ad ventitia transduced with AdCMVeNOS, and causes sub sequent cGMP formation and relaxations of arterial smooth muscle. In AdCMVeNOS-transduced basilar arteries without endothelium, ET-2 also caused relaxations during UTP induced contractions, however, ET-3 did not produce any relaxations. Previous studies have indicated that ET -1 and ET -z2 exhibit relatively higher affinity for ETA receptors than ET-3 (Arai et a!., 1990; Sakurai et a!., 1990) . In addition, sarafotoxin, a selective ET B receptor agonist (Hey I et a!., 1993; Williams et aI., 1991) , did not induce relaxations in arteries transduced with AdCMVeNOS, suggesting that activation of ETA recep tors located on the vascular adventitia is involved in the relaxations to ET-1 and ET-2. This concept is further supported by the present results showing that BQ-123, a selective ETA receptor antagonist (Douglas, Meek and Ohlstein, 1994; Ihara et aI., 1995) , almost abolished ET I-induced relaxations, whereas BQ-788, a selective ET B receptor antagonist (Ishikawa et aI., 1994; Karaki, Sud jarwo and Hori, 1994) was without effect. In our previ ous ex vivo and in vivo gene transfer studies on canine cerebral arteries, electron microscopy immunogold label ing indicated that expression of recombinant eNOS pro tein was localized to adventitial fibroblasts (Chen et aI., 1997a; Tsutsui et aI., 1998) . Existing evidence suggests that ET receptors are present on fibroblasts, and that activation of these receptors leads to increase in intracel lular free Ca 2 + concentration (Gardner, Maher and Aviv, 1989; Ohnishi-Suzaki et aI., 1990; Peacock et aI., 1992) . Therefore, it is very likely that ET -1 may activate re combinant eNOS enzyme via ETA receptor-mediated in crease in intracellular Ca 2 +, thereby facilitating produc tion of NO in adventitial fibroblasts.
ET -1 caused concentration-dependent contractions in arteries that were not contracted by UTP. These con tractions were significantly reduced in arteries with AdCMVeNOS transduction. The effect of recombinant eNOS was comparable in arteries with and without en dothelial cells, suggesting that release of NO from the adventitia was responsible for the suppression of con tractile responses to ET -l. The selectivity of recombinant eNOS inhibitory effect on contractions to ET -1 was shown by the fact that contractions to UTP were identical in AdCMV[3-Gal-transduced and AdCMVeNOS transduced arteries.
In the cerebral circulation, ET -1 is regarded as a pu- tative mediator of cerebral vasospasm after subarachnoid hemorrhage (Asano et aI., 1989; Cosentino and Katusic, 1994; Suzuki et aI., 1992; Willette et aI., 1994; Zuc carello et aI., 1996) . An exact pathogenesis of this arte rial narrowing is not completely understood; however, it has been postulated that occurrence of vasospasm corre lates with an increase of ET -1 concentrations in plasma and CSF (Ehrenreich et aI., 1992; Suzuki et aI., 1990; Suzuki et aI., 1992) . In addition, decreased availability of NO is thought to be an important factor responsible for the development of vasospasm (Katusic et aI., 1993; Macdonald and Weir, 1991; Pluta et aI., 1996) . Our re sults indicate that expression of recombinant eNOS gene may have beneficial effect due to (1) restoration of NO formation and (2) reversal of vasoconstrictor effect of ET-l into relaxations. A recent study has shown that perivascular expression of recombinant [3-galactosidase could be obtained by intracisternal injection of adenovi ral vectors in dogs with developed vasospasm after sub arachnoid hemorrhage (Muhonen et aI., 1997) . There fore, the delivery of adenoviral vectors with functional expression of recombinant eNOS in cerebral arteries may provide a feasible approach to prevent cerebral vaso spasm.
The present study shows that contractile responses to ET -1 could be reversed to relaxations by adventitial ex pression of recombinant eNOS gene. This novel vasodi lator mechanism may have important implications in de velopment of gene therapy for various vascular disorders associated with enhanced ET -1 production.
